Prostate-Specific Antigen (PSA) Testing Market 2027 by Tests type, Assays type | The Insight Partners

Prostate-Specific Antigen (PSA) Testing Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Tests type (Total Prostate Specific Antigen Test (tPSA), Complex Prostate Specific Antigen Test (cPSA), Free Prostate Specific Antigen Test (fPSA), Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test (PSA RT-PCR), PCA3Test, Trans-rectal Ultrasound, Biopsy); Assays type (Radioimmunoassay (RIA), Enzyme Immunoassay (EIA))

Report Code: TIPRE00008486 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Prostate-specific antigen (PSA) is a type of glycoprotein secreted by prostatic epithelial cells. The higher levels of the PSA indicate a higher chance of being affected by prostate cancer. Though not a prostate-specific molecule, its elevated presence in blood serum is used to detect prostate cancer among men. Increased levels of PSA are associated with prostatitis, an inflammation of the prostate gland, or is indicative of a benign form of prostatic hyperplasia.

MARKET DYNAMICS

The prostate-specific antigen (PSA) testing market is anticipated to grow owing to the rise in awareness levels regarding the availability of advanced cancer diagnostics technologies, especially in the emerging regions. However, increasing the prevalence of the disease will have a significant impact on market development. Moreover, supportive initiatives by various governments across the globe drive market growth.

MARKET SCOPE

The "Prostate-Specific Antigen (PSA) Testing Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in prostate-specific antigen (PSA) testing market with detailed market segmentation by test type, assays type and geography. The prostate-specific antigen (PSA) testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in prostate-specific antigen (PSA) testing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The prostate-specific antigen (PSA) testing market is segmented on the basis of test type and assays type. Based on test type the market is segmented as total prostate specific antigen test (tPSA), complex prostate specific antigen test (cPSA), free prostate specific antigen test (fPSA), prostate specific antigen reverse transcription polymerase chain reaction test (PSA RT-PCR), PCA3test, trans-rectal ultrasound and Biopsy. On the basis of assays type the market is categorized as radioimmunoassay (RIA) and enzyme immunoassay (EIA).

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in prostate-specific antigen (PSA) testing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The prostate-specific antigen (PSA) testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting prostate-specific antigen (PSA) testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the prostate-specific antigen (PSA) testing market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in prostate-specific antigen (PSA) testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in prostate-specific antigen (PSA) testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for in prostate-specific antigen (PSA) testing market in the global market. Below mentioned is the list of few companies engaged in the prostate-specific antigen (PSA) testing market.

The report also includes the profiles of key in prostate-specific antigen (PSA) testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Abbott Laboratories, Inc.
- AstraZeneca plc.
- Bayer AG
- Beckman Coulter, Inc.
- Bristol - Myers Squibb Company
- GE Healthcare
- GlaxoSmithKline, plc
- Merck & Co., Inc.
- Novartis Pharma AG
- UroLogix, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Prostate-specific Antigen (PSA) Testing Market - By Tests type
1.3.2 Prostate-specific Antigen (PSA) Testing Market - By Assays type
1.3.3 Prostate-specific Antigen (PSA) Testing Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING - GLOBAL MARKET OVERVIEW
6.2. PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET - REVENUE AND FORECASTS TO 2027 - TESTS TYPE
7.1. OVERVIEW
7.2. TESTS TYPE MARKET FORECASTS AND ANALYSIS
7.3. TOTAL PROSTATE SPECIFIC ANTIGEN TEST (TPSA)
7.3.1. Overview
7.3.2. Total Prostate Specific Antigen Test (tPSA) Market Forecast and Analysis
7.4. COMPLEX PROSTATE SPECIFIC ANTIGEN TEST (CPSA)
7.4.1. Overview
7.4.2. Complex Prostate Specific Antigen Test (cPSA) Market Forecast and Analysis
7.5. FREE PROSTATE SPECIFIC ANTIGEN TEST (FPSA)
7.5.1. Overview
7.5.2. Free Prostate Specific Antigen Test (fPSA) Market Forecast and Analysis
7.6. PROSTATE SPECIFIC ANTIGEN REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION TEST (PSA RT-PCR)
7.6.1. Overview
7.6.2. Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test (PSA RT-PCR) Market Forecast and Analysis
7.7. PCA3TEST
7.7.1. Overview
7.7.2. PCA3Test Market Forecast and Analysis
7.8. TRANS-RECTAL ULTRASOUND
7.8.1. Overview
7.8.2. Trans-rectal Ultrasound Market Forecast and Analysis
7.9. BIOPSY
7.9.1. Overview
7.9.2. Biopsy Market Forecast and Analysis
8. PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET - REVENUE AND FORECASTS TO 2027 - ASSAYS TYPE
8.1. OVERVIEW
8.2. ASSAYS TYPE MARKET FORECASTS AND ANALYSIS
8.3. RADIOIMMUNOASSAY (RIA)
8.3.1. Overview
8.3.2. Radioimmunoassay (RIA) Market Forecast and Analysis
8.4. ENZYME IMMUNOASSAY (EIA)
8.4.1. Overview
8.4.2. Enzyme Immunoassay (EIA) Market Forecast and Analysis
9. PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Prostate-specific Antigen (PSA) Testing Market Overview
9.1.2 North America Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis
9.1.3 North America Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis - By Tests type
9.1.4 North America Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis - By Assays type
9.1.5 North America Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis - By Countries
9.1.5.1 United States Prostate-specific Antigen (PSA) Testing Market
9.1.5.1.1 United States Prostate-specific Antigen (PSA) Testing Market by Tests type
9.1.5.1.2 United States Prostate-specific Antigen (PSA) Testing Market by Assays type
9.1.5.2 Canada Prostate-specific Antigen (PSA) Testing Market
9.1.5.2.1 Canada Prostate-specific Antigen (PSA) Testing Market by Tests type
9.1.5.2.2 Canada Prostate-specific Antigen (PSA) Testing Market by Assays type
9.1.5.3 Mexico Prostate-specific Antigen (PSA) Testing Market
9.1.5.3.1 Mexico Prostate-specific Antigen (PSA) Testing Market by Tests type
9.1.5.3.2 Mexico Prostate-specific Antigen (PSA) Testing Market by Assays type
9.2. EUROPE
9.2.1 Europe Prostate-specific Antigen (PSA) Testing Market Overview
9.2.2 Europe Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis
9.2.3 Europe Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis - By Tests type
9.2.4 Europe Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis - By Assays type
9.2.5 Europe Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Prostate-specific Antigen (PSA) Testing Market
9.2.5.1.1 Germany Prostate-specific Antigen (PSA) Testing Market by Tests type
9.2.5.1.2 Germany Prostate-specific Antigen (PSA) Testing Market by Assays type
9.2.5.2 France Prostate-specific Antigen (PSA) Testing Market
9.2.5.2.1 France Prostate-specific Antigen (PSA) Testing Market by Tests type
9.2.5.2.2 France Prostate-specific Antigen (PSA) Testing Market by Assays type
9.2.5.3 Italy Prostate-specific Antigen (PSA) Testing Market
9.2.5.3.1 Italy Prostate-specific Antigen (PSA) Testing Market by Tests type
9.2.5.3.2 Italy Prostate-specific Antigen (PSA) Testing Market by Assays type
9.2.5.4 Spain Prostate-specific Antigen (PSA) Testing Market
9.2.5.4.1 Spain Prostate-specific Antigen (PSA) Testing Market by Tests type
9.2.5.4.2 Spain Prostate-specific Antigen (PSA) Testing Market by Assays type
9.2.5.5 United Kingdom Prostate-specific Antigen (PSA) Testing Market
9.2.5.5.1 United Kingdom Prostate-specific Antigen (PSA) Testing Market by Tests type
9.2.5.5.2 United Kingdom Prostate-specific Antigen (PSA) Testing Market by Assays type
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Overview
9.3.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis
9.3.3 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis - By Tests type
9.3.4 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis - By Assays type
9.3.5 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Prostate-specific Antigen (PSA) Testing Market
9.3.5.1.1 Australia Prostate-specific Antigen (PSA) Testing Market by Tests type
9.3.5.1.2 Australia Prostate-specific Antigen (PSA) Testing Market by Assays type
9.3.5.2 China Prostate-specific Antigen (PSA) Testing Market
9.3.5.2.1 China Prostate-specific Antigen (PSA) Testing Market by Tests type
9.3.5.2.2 China Prostate-specific Antigen (PSA) Testing Market by Assays type
9.3.5.3 India Prostate-specific Antigen (PSA) Testing Market
9.3.5.3.1 India Prostate-specific Antigen (PSA) Testing Market by Tests type
9.3.5.3.2 India Prostate-specific Antigen (PSA) Testing Market by Assays type
9.3.5.4 Japan Prostate-specific Antigen (PSA) Testing Market
9.3.5.4.1 Japan Prostate-specific Antigen (PSA) Testing Market by Tests type
9.3.5.4.2 Japan Prostate-specific Antigen (PSA) Testing Market by Assays type
9.3.5.5 South Korea Prostate-specific Antigen (PSA) Testing Market
9.3.5.5.1 South Korea Prostate-specific Antigen (PSA) Testing Market by Tests type
9.3.5.5.2 South Korea Prostate-specific Antigen (PSA) Testing Market by Assays type
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Overview
9.4.2 Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis
9.4.3 Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis - By Tests type
9.4.4 Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis - By Assays type
9.4.5 Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Prostate-specific Antigen (PSA) Testing Market
9.4.5.1.1 South Africa Prostate-specific Antigen (PSA) Testing Market by Tests type
9.4.5.1.2 South Africa Prostate-specific Antigen (PSA) Testing Market by Assays type
9.4.5.2 Saudi Arabia Prostate-specific Antigen (PSA) Testing Market
9.4.5.2.1 Saudi Arabia Prostate-specific Antigen (PSA) Testing Market by Tests type
9.4.5.2.2 Saudi Arabia Prostate-specific Antigen (PSA) Testing Market by Assays type
9.4.5.3 U.A.E Prostate-specific Antigen (PSA) Testing Market
9.4.5.3.1 U.A.E Prostate-specific Antigen (PSA) Testing Market by Tests type
9.4.5.3.2 U.A.E Prostate-specific Antigen (PSA) Testing Market by Assays type
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Prostate-specific Antigen (PSA) Testing Market Overview
9.5.2 South and Central America Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis
9.5.3 South and Central America Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis - By Tests type
9.5.4 South and Central America Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis - By Assays type
9.5.5 South and Central America Prostate-specific Antigen (PSA) Testing Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Prostate-specific Antigen (PSA) Testing Market
9.5.5.1.1 Brazil Prostate-specific Antigen (PSA) Testing Market by Tests type
9.5.5.1.2 Brazil Prostate-specific Antigen (PSA) Testing Market by Assays type
9.5.5.2 Argentina Prostate-specific Antigen (PSA) Testing Market
9.5.5.2.1 Argentina Prostate-specific Antigen (PSA) Testing Market by Tests type
9.5.5.2.2 Argentina Prostate-specific Antigen (PSA) Testing Market by Assays type
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASTRAZENECA PLC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BAYER AG
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BECKMAN COULTER, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BRISTOL - MYERS SQUIBB COMPANY
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. GE HEALTHCARE
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. GLAXOSMITHKLINE, PLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MERCK AND CO., INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. NOVARTIS PHARMA AG
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. UROLOGIX, INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories, Inc.
2. AstraZeneca plc.
3. Bayer AG
4. Beckman Coulter, Inc.
5. Bristol - Myers Squibb Company
6. GE Healthcare
7. GlaxoSmithKline, plc
8. Merck & Co., Inc.
9. Novartis Pharma AG
10. UroLogix, Inc.
TIPRE00008486
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking